Compton Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,015
| Closed | -$332K | – | 80 |
|
|
2022
Q3 | $332K | Sell |
4,015
-200
| -5% | -$16.5K | 0.22% | 65 |
|
|
2022
Q2 | $401K | Sell |
4,215
-400
| -9% | -$38.1K | 0.22% | 71 |
|
|
2022
Q1 | $543K | Sell |
4,615
-200
| -4% | -$23.5K | 0.15% | 109 |
|
|
2021
Q4 | $624K | Hold |
4,815
| – | – | 0.16% | 100 |
|
|
2021
Q3 | $545K | Hold |
4,815
| – | – | 0.16% | 105 |
|
|
2021
Q2 | $499K | Sell |
4,815
-50
| -1% | -$5.18K | 0.15% | 109 |
|
|
2021
Q1 | $407K | Hold |
4,865
| – | – | 0.13% | 121 |
|
|
2020
Q4 | $444K | Hold |
4,865
| – | – | 0.15% | 102 |
|
|
2020
Q3 | $388K | Hold |
4,865
| – | – | 0.15% | 101 |
|
|
2020
Q2 | $336K | Buy |
4,865
+50
| +1% | +$3.45K | 0.14% | 105 |
|
|
2020
Q1 | $303K | Buy |
4,815
+600
| +14% | +$37.8K | 0.15% | 100 |
|
|
2019
Q4 | $328K | Hold |
4,215
| – | – | 0.13% | 112 |
|
|
2019
Q3 | $309K | Sell |
4,215
-8,175
| -66% | -$599K | 0.13% | 113 |
|
|
2019
Q2 | $763K | Hold |
12,390
| – | – | 0.32% | 78 |
|
|
2019
Q1 | $790K | Sell |
12,390
-675
| -5% | -$43K | 0.34% | 73 |
|
|
2018
Q4 | $667K | Sell |
13,065
-450
| -3% | -$23K | 0.32% | 80 |
|
|
2018
Q3 | $784K | Hold |
13,515
| – | – | 0.31% | 81 |
|
|
2018
Q2 | $656K | Hold |
13,515
| – | – | 0.28% | 87 |
|
|
2018
Q1 | $629K | Sell |
13,515
-450
| -3% | -$20.9K | 0.27% | 93 |
|
|
2017
Q4 | $525K | Buy |
13,965
+6,390
| +84% | +$240K | 0.22% | 99 |
|
|
2017
Q3 | $276K | Buy |
7,575
+750
| +11% | +$27.3K | 0.12% | 122 |
|
|
2017
Q2 | $269K | Hold |
6,825
| – | – | 0.12% | 126 |
|
|
2017
Q1 | $214K | Buy |
+6,825
| New | +$214K | 0.11% | 132 |
|